Idenix Pharma Initiates Phase II Study
Yahoo/Zacks
Achillion: Moving Beyond Sofosbuvir's Shadow
Seeking Alpha
3 Horrendous Health-Care Stocks This Week
Motley Fool
Idenix Pharmaceuticals Announces Decision by the United States Patent and Trademark Office Patent Trial and Appeal Board
Yahoo/GlobeNewsWire
Hepatitis C In Play for 2013?
Motley Fool
Idenix Pharma ends development of 2 hepatitis C drugs after regulators signal further holds
Yahoo/AP
3 Horrendous Health-Care Stocks This Week
Motley Fool

